Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Otto

Showing results (401-410 of 632) with videos related to

Pageof 64
Sort By:
Psychiatric Services (Washington, D.C.)|June 5, 2002
Quality of life in social anxiety disorder compared with panic disorder and the general populationNaomi M Simon, Michael W Otto, Nicole B Korbly, et al.
Contemporary Clinical Trials|June 27, 2015
Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationaleStefan G Hofmann, Joseph K Carpenter, Michael W Otto, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|April 24, 2010
Predictors of relapse in the second follow-up year post cognitive-behavior therapy for panic disorderElizeth Heldt, Letícia Kipper, Carolina Blaya, et al.
Behaviour Research and Therapy|June 16, 2010
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluationMichael W Otto, R Kathryn McHugh, Naomi M Simon, et al.
Journal of Affective Disorders|November 25, 1996
Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorderG G Manfro, M W Otto, E T McArdle, et al.
Disease Models & Mechanisms|June 20, 2019
Conserved properties of genetic architecture of renal and fat transcriptomes in rat models of insulin resistanceGeorg W Otto, Pamela J Kaisaki, Francois Brial, et al.
Contemporary Clinical Trials|September 20, 2023
Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trialKate Wolitzky-Taylor, Larissa J Mooney, Michael W Otto, et al.
Journal of Affective Disorders|May 17, 2005
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic statesNaomi M Simon, Michael W Otto, Diana Fischmann, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Exercise for mood and anxiety disordersMichael W Otto, Timothy S Church, Lynette L Craft, et al.
Psychology, Health & Medicine|June 28, 2017
Body Mass Index and functional impairment: the explanatory role of anxiety sensitivity among treatment-seeking smokersBrooke Y Kauffman, Lorra Garey, Charles Jardin, et al.
Pageof 64

Showing results (401-410 of 632) with videos related to

Sort By:
Pageof 64
Psychiatric Services (Washington, D.C.)|June 5, 2002
Quality of life in social anxiety disorder compared with panic disorder and the general populationNaomi M Simon, Michael W Otto, Nicole B Korbly, et al.
Contemporary Clinical Trials|June 27, 2015
Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationaleStefan G Hofmann, Joseph K Carpenter, Michael W Otto, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|April 24, 2010
Predictors of relapse in the second follow-up year post cognitive-behavior therapy for panic disorderElizeth Heldt, Letícia Kipper, Carolina Blaya, et al.
Behaviour Research and Therapy|June 16, 2010
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluationMichael W Otto, R Kathryn McHugh, Naomi M Simon, et al.
Journal of Affective Disorders|November 25, 1996
Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorderG G Manfro, M W Otto, E T McArdle, et al.
Disease Models & Mechanisms|June 20, 2019
Conserved properties of genetic architecture of renal and fat transcriptomes in rat models of insulin resistanceGeorg W Otto, Pamela J Kaisaki, Francois Brial, et al.
Contemporary Clinical Trials|September 20, 2023
Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trialKate Wolitzky-Taylor, Larissa J Mooney, Michael W Otto, et al.
Journal of Affective Disorders|May 17, 2005
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic statesNaomi M Simon, Michael W Otto, Diana Fischmann, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Exercise for mood and anxiety disordersMichael W Otto, Timothy S Church, Lynette L Craft, et al.
Psychology, Health & Medicine|June 28, 2017
Body Mass Index and functional impairment: the explanatory role of anxiety sensitivity among treatment-seeking smokersBrooke Y Kauffman, Lorra Garey, Charles Jardin, et al.
Pageof 64